iiinova — where your digital self keeps evolving

Alliance for Clinical Trials in Oncology @alliance-org.bsky.social · 11h

New lung cancer trial open 🧪🫁 Alliance A082402 is studying if targeted post op radiation (I² PORT) can reduce recurrence in high risk #NSCLC patients after surgery while limiting side effects. Learn more bit.ly/I-PORT-Trial. #LungCancer #ClinicalTrials #RadiationTherapy

000

Alliance for Clinical Trials in Oncology @alliance-org.bsky.social · 30/09/2026

Results from the Alliance RadiCaL (A031801) trial led by Dr. Rana McKay in JCO by American Society of Clinical Oncology found that adding radium-223 does not improve time people with kidney cancer went without bone complications. News - bit.ly/Radical26. Article - bit.ly/Radical-JCO

000

Alliance for Clinical Trials in Oncology @alliance-org.bsky.social · 30/09/2026

Discover the latest advances in breast, lung & prostate cancer care! Join the Alliance for a free public webinar on Oct 1 featuring leading researchers & patient advocates sharing key findings from #ASCO26. Register now: bit.ly/Alliance-Webinar-Oct26 #clinicaltrials

100

Alliance for Clinical Trials in Oncology @alliance-org.bsky.social · 29/09/2026

More than 192K Americans will face a blood cancer diagnosis this year—one every 3 minutes. This #BloodCancerAwarenessMonth, the Alliance is highlighting 11 active trials driving research in precision therapies, immunotherapy, and survivorship. More at bit.ly/BloodCa

001

Alliance for Clinical Trials in Oncology @alliance-org.bsky.social · 29/09/2026

Now enrolling! Led by Maryam Lustberg, a new trial tackles a common but overlooked side effect of breast cancer treatment. The #REVITALIZE study (Alliance A221801) is testing laser therapy to relieve chronic vaginal dryness and improve quality of life for survivors. 💗🧪 bit.ly/REVITALIZE2026

000

Alliance for Clinical Trials in Oncology @alliance-org.bsky.social · 28/09/2026

Late-breaking news from #ASTRO26: Alliance for Clinical Trials in Oncology Phase III trial (A071801) finds 3-5 sessions of radiosurgery after surgery for large brain metastases outperforms single-session treatment in reducing local recurrence and boosting survival. bit.ly/ASTRO26

021

Alliance for Clinical Trials in Oncology @alliance-org.bsky.social · 28/09/2026

Enrolling! Drs. Thomas Hope of UCSF Helen Diller Family Comprehensive Cancer Center and Suki Padda of @foxchasecancer.bsky.social lead A021901/B-LuRE trial comparing a radioactive drug to chemotherapy treatment in patients with bronchial #neuroendocrine tumors. More: bit.ly/Alliance-A021901

000

Alliance for Clinical Trials in Oncology @alliance-org.bsky.social · 28/09/2026

001

Alliance for Clinical Trials in Oncology @alliance-org.bsky.social · 25/09/2026

Now enrolling! Dr. Adrienne Waks of Dana-Farber Cancer Institute leads A012303 (ShortStop-HER2), a phase III study testing if less treatment after surgery is an option for people with early-stage HER2+ #breastcancer who had no cancer left after chemo + HER2 therapy. bit.ly/Alliance-A012303

000

Alliance for Clinical Trials in Oncology @alliance-org.bsky.social · 24/09/2026

010

Alliance for Clinical Trials in Oncology @alliance-org.bsky.social · 24/09/2026

Now enrolling! BCG (a bladder immunotherapy) is standard for non-muscle invasive bladder cancer. For cancer that returns after BCG, Alliance A032103 (GAIN) trial tests adding gemcitabine—a chemo drug—to BCG to prevent recurrence. Learn more: bit.ly/Alliance-GAIN-BCG #BladderCancer

000

Alliance for Clinical Trials in Oncology @alliance-org.bsky.social · 23/09/2026

Dr. Anne Beaven of UNC Lineberger Comprehensive Cancer Center leads Alliance A052101, a trial to see if older people with mantle cell lymphoma can receive fewer treatments of the targeted cancer medicine zanubrutinib while in remission. More: bit.ly/Alliance-A052101 #bloodcancerawareness

010

Alliance for Clinical Trials in Oncology @alliance-org.bsky.social · 22/09/2026

000

Alliance for Clinical Trials in Oncology @alliance-org.bsky.social · 22/09/2026

Trial Tuesday! Jennifer Ligibel MD of the Dana-Farber and Kathryn Schmitz PhD of @upmchillmancc.bsky.social lead Alliance A222302 studying the feasibility of a telehealth exercise program for cancer patients with the goal of reducing fatigue and disability. bit.ly/DEFEND-trial #oncsky #nci

010

Alliance for Clinical Trials in Oncology @alliance-org.bsky.social · 21/09/2026

Now enrolling! The phase III HOPE study (A222301) led by Anurag Singh, MD of Roswell Park Comprehensive Cancer Center is assessing whether high-dose gabapentin reduces opioid use in patients with oral mucositis from chemoradiation for head and neck cancer. More at bit.ly/Alliance-A222301

000

Alliance for Clinical Trials in Oncology @alliance-org.bsky.social · 21/09/2026

September is #ProstateCancerAwarenessMonth! 💙From precision diagnostics and targeted therapies to telehealth exercise programs, Alliance clinical trials are driving the next generation of cancer care. Learn more about our current trials at 👇 bit.ly/Prostate2026

000

Alliance for Clinical Trials in Oncology @alliance-org.bsky.social · 21/09/2026

Dr. Ugonma Chukwueke of Dana-Farber Cancer Institute leads a new Alliance trial exploring if adding a targeted medicine called vorasidenib to the usual treatment helps people with newly diagnosed IDH mutated grade 3 astrocytoma, a brain cancer. bit.ly/Brain2026 #clinicaltrials #oncsky

000

Alliance for Clinical Trials in Oncology @alliance-org.bsky.social · 21/09/2026

Thank you for sharing our powerful five-minute video @eaonc.bsky.social! I really helps frame clinical trials from the participant's point of view.

011

Alliance for Clinical Trials in Oncology @alliance-org.bsky.social · 19/09/2026

001

Alliance for Clinical Trials in Oncology @alliance-org.bsky.social · 18/09/2026

Led by Devon Noonan of Duke Cancer Institute, A211901 offers personalized text-message support to help rural cancer survivors quit smoking. No travel required—get guidance on smoking cessation directly on your phone. Check study details: 🔗 bit.ly/Alliance-A211901 #SmokingCessation

000

Alliance for Clinical Trials in Oncology @alliance-org.bsky.social · 18/09/2026

Drs. Rana McKay of UC San Diego and Misha Meltran Dana-Farber co-lead Alliance A032102/PREDICT evaluating if genetic testing helps determine the best treatment regimen for men with metastatic prostate cancer. Learn more: bit.ly/Alliance-A032102 #PCsm

000

Alliance for Clinical Trials in Oncology @alliance-org.bsky.social · 17/09/2026

🚨 Milestone reached: The ERASur colorectal cancer trial has surpassed one third patient accrual nationwide. The study is evaluating whether aggressive local therapy can improve survival in limited metastatic disease. #ClinicalTrials #ColorectalCancer bit.ly/ERASur26

000

Alliance for Clinical Trials in Oncology @alliance-org.bsky.social · 17/09/2026

000

Alliance for Clinical Trials in Oncology @alliance-org.bsky.social · 17/09/2026

Thomas Hope of UCSF Helen Diller Family Comprehensive Cancer Center and Deaglan McHugh of Memorial Sloan Kettering Cancer Center lead Alliance A032304 (RECIPROCAL), a prostate cancer trial aiming to optimize radiation & minimize side effects while preserving efficacy. bit.ly/AllianceA032304

000

Alliance for Clinical Trials in Oncology @alliance-org.bsky.social · 16/09/2026

New trial! The Alliance has a new trial for adults who need first-line therapy for chronic lymphocytic leukemia or small lymphocytic lymphoma. Visit bit.ly/CLL-SLL to learn about Alliance A042302 led by Dr. Jennifer R. Brown of Dana-Farber Cancer Institute #bloodcancerawareness

000

Alliance for Clinical Trials in Oncology @alliance-org.bsky.social · 15/09/2026

Sara Tolaney of Dana-Farber Cancer Institute leads Alliance A012103 for early-stage breast cancer patients with complete response after chemo + pembrolizumab. This phase III trial compares continuing pembrolizumab vs monitoring after surgery. Learn more: bit.ly/Alliance-A012103

000

Alliance for Clinical Trials in Oncology @alliance-org.bsky.social · 15/09/2026

AFT study in American Society of Clinical Oncology's JCOOA shows simple weekly digital symptom check-in improves quality of life and reduces emergency room visits for patients with advanced cancer by bridging communication gaps. News release - bit.ly/AFT-39. Study: bit.ly/AFT39-JCO

010

Alliance for Clinical Trials in Oncology @alliance-org.bsky.social · 14/09/2026

000

Alliance for Clinical Trials in Oncology @alliance-org.bsky.social · 14/09/2026

Dr. Haeseong Park of the Dana-Farber leads Alliance A022102 studying mFOLFIRINOX vs mFOLFOX with or without immunotherapy drug nivolumab for metastatic HER2 negative esophageal, gastroesophageal junction and gastric cancer. More: bit.ly/Alliance-A022102 #ColorectalCancer

000

Alliance for Clinical Trials in Oncology @alliance-org.bsky.social · 14/09/2026

The new QUANTUM trial led by Dr. Douglas Sborov at @huntsmancancer.bsky.social is testing if adding teclistamab after stem cell transplant helps improve long-term survival for people with rare plasma cell leukemia.🔗 bit.ly/QUANTUM-trial #bloodcancerawareness #clinicaltrials

010

Alliance for Clinical Trials in Oncology @alliance-org.bsky.social · 13/09/2026

000

Alliance for Clinical Trials in Oncology @alliance-org.bsky.social · 11/09/2026

Led by Aaron Mansfield, MD, of the Mayo Clinic, a new trial is testing immunotherapy given before surgery for people diagnosed with non-epithelioid or sarcomatoid mesothelioma, a type of lung cancer. Check locations and eligibility at 🔗 bit.ly/Alliance-A082101 #CancerCare #ClinicalTrial

011

Alliance for Clinical Trials in Oncology @alliance-org.bsky.social · 11/09/2026

Now enrolling! Angela Bradbury MD Penn Cancer leads Alliance A232301CD seeing if digital chatbot intervention is as effective as standard remote genetic services in increasing counseling uptake among #AYA #cancer patients bit.ly/AllianceA232301CD #AYAWeek #AYACancerAwareness

000

Alliance for Clinical Trials in Oncology @alliance-org.bsky.social · 10/09/2026

Deadline tomorrow! Know an "unsung hero" in cancer clinical trials research? 🩺✨ Nominations are open for the 2026 Richard L. Schilsky CALGB Achievement Award! Help Alliance for Clinical Trials in Oncology honor those making a difference! 🗓️ Deadline: Sept 11 🔗 bit.ly/Schilsky26 #oncsky

100

Alliance for Clinical Trials in Oncology @alliance-org.bsky.social · 10/09/2026

📢 New Clinical Trial: Alliance A082302 is studying if immunotherapy after surgery prevents recurrence in early non-small cell lung cancer (#NSCLC). The trial aims to enroll 336 participants to move from passive observation to active prevention. More at bit.ly/43SStJU.

010

Alliance for Clinical Trials in Oncology @alliance-org.bsky.social · 09/09/2026

With colorectal cancer, if a person has an inherited gene change, other family members are at risk. Alliance A212101 will see if family members are more likely to get genetic testing to catch disease early if they hear from a healthcare provider. More at bit.ly/CRCGene-Testing

000

Alliance for Clinical Trials in Oncology @alliance-org.bsky.social · 08/09/2026

Now enrolling! Bhavana Konda, MD, MPH, of Ohio State University leads @alliance_org A092204 exploring if using two targeted medications can help slow tumor growth in #AYA with advanced adrenocortical carcinoma, a rare cancer of the adrenal glands. bit.ly/A092204-Konda

000

Alliance for Clinical Trials in Oncology @alliance-org.bsky.social · 07/09/2026

Dr. Brad McGregor of Dana-Farber leads Alliance A032201 (STRIKE) to see if adding the anti-cancer drug tivozanib to the standard treatment of immunotherapy after surgery helps patients with high-risk renal cell cancer. Learn more: bit.ly/Alliance-A032201 #NCI #NCTN #PCSM

010

Alliance for Clinical Trials in Oncology @alliance-org.bsky.social · 07/09/2026

Recognize research excellence! 🔬 Nominations are due Sept 18, for the prestigious Charles G. Moertel Lecture (Community Practice). Learn more about the award and nomination info at 👉 bit.ly/4vXnicO

000

Alliance for Clinical Trials in Oncology @alliance-org.bsky.social · 06/09/2026

Deadline extended! Know an "unsung hero" in cancer clinical trials research? 🩺✨ Nominations are open for the 2026 Richard L. Schilsky CALGB Achievement Award! Help Alliance for Clinical Trials in Oncology honor those making a difference! 🗓️ Deadline: Sept 11 🔗 bit.ly/Schilsky26 #oncsky

000

Alliance for Clinical Trials in Oncology @alliance-org.bsky.social · 04/09/2026

000

Alliance for Clinical Trials in Oncology @alliance-org.bsky.social · 04/09/2026

ERAsur has gone global! Led by Dr. Eric Miller of @OhioStateMed, Alliance A022101 aimed at improving colorectal cancer survival is now active to patients in Canada and Mexico with sites in Colombia and Chile expected to begin later this month. bit.ly/ERAsur Colorectal Cancer Canada

000

Alliance for Clinical Trials in Oncology @alliance-org.bsky.social · 04/09/2026

000

Alliance for Clinical Trials in Oncology @alliance-org.bsky.social · 03/09/2026

Alliance for Clinical Trials in Oncology trial enrolling! Dr. Gabe Brooks of Dartmouth Cancer leads the PAGODA trial (A232402CD) aimed at reducing unplanned treatment delays in people with gastrointestinal cancers. Learn more at bit.ly/PAGODA26. #ColorectalCancer #OncSky #ClinicalTrials

000

Alliance for Clinical Trials in Oncology @alliance-org.bsky.social · 02/09/2026

Now enrolling: Alliance A071401 led by Dr. Priscilla Brastianos of Mass General is enrolling patients with progressive meningioma. This study evaluates biomarker-driven targeted agents based on specific genetic mutations. Full protocol at 👇 🔗 bit.ly/A071401-trial #oncsky

000

Alliance for Clinical Trials in Oncology @alliance-org.bsky.social · 01/09/2026

000

Alliance for Clinical Trials in Oncology @alliance-org.bsky.social · 01/09/2026

010

Alliance for Clinical Trials in Oncology @alliance-org.bsky.social · 31/08/2026

000

Alliance for Clinical Trials in Oncology @alliance-org.bsky.social · 31/08/2026

Drs. Thomas Hope of UCSF Helen Diller Family Comprehensive Cancer Center & Suki Padda of @foxchasecancer.bsky.social lead Alliance A021901/B-LuRE trial comparing a radioactive drug to chemotherapy treatment in patients with bronchial #neuroendocrine tumors. bit.ly/Alliance-A021901 #oncsky

000

Alliance for Clinical Trials in Oncology @alliance-org.bsky.social · 31/08/2026

Clinical trials help advance cancer research and care—but they depend on people willing to participate. Our new film shares one participant’s story and the vital role volunteers play in improving cancer treatment. You can view the five-minute #RewritingCancer film here: bit.ly/Alliance-Video

010